title: ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
abstract: BACKGROUND
  Understanding the effects of interactions between multiple genes and asthma medications may aid in the understanding of the heterogeneous response to asthma therapies.
  
  
  OBJECTIVE
  To identify modulating effects of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) gene polymorphisms on the drug-drug interaction between leukotriene modifiers and albuterol in Mexicans and Puerto Ricans.
  
  
  METHODS
  In a cross-sectional study of 293 Mexicans and 356 Puerto Ricans with asthma, ALOX5AP and LTA4H genes were sequenced, and interactions between gene polymorphisms and bronchodilator responsiveness to albuterol were compared between leukotriene modifier users and nonusers.
  
  
  RESULTS
  In heterozygotes and homozygotes for the minor allele at LTA4H single nucleotide polymorphism (SNP) rs2540491 and heterozygotes for the major allele at LTA4H SNP rs2540487, leukotriene modifier use was associated with a clinically significant increase in percent change in FEV(1) after albuterol administration of 7.10% (P = .002), 10.06% (P = .001), and 10.03% (P < .001), respectively. Presence of the major allele at ALOX5AP SNP rs10507391 or the minor allele at ALOX5AP SNP rs9551963 augmented this response. When stratified by ethnicity, these findings held true for Puerto Ricans but not Mexicans.
  
  
  CONCLUSIONS
  LTA4H and ALOX5AP gene polymorphisms modify the augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Ricans but not Mexicans with asthma.
authors.affiliation: Allergy/Immunology Associates, Inc, and Case Western Reserve University, Cleveland, Ohio, USA. haig.tcheurekdjian@gmail.com
authors.forename: Haig
authors.initials: H
authors.lastname: Tcheurekdjian
authors.forename: Marc
authors.initials: M
authors.lastname: Via
authors.forename: Anthony
authors.initials: A
authors.lastname: De Giacomo
authors.forename: Harriet
authors.initials: H
authors.lastname: Corvol
authors.forename: Celeste
authors.initials: C
authors.lastname: Eng
authors.forename: Shannon
authors.initials: S
authors.lastname: Thyne
authors.forename: Rocio
authors.initials: R
authors.lastname: Chapela
authors.forename: William
authors.initials: W
authors.lastname: Rodriguez-Cintron
authors.forename: Jose R
authors.initials: JR
authors.lastname: Rodriguez-Santana
authors.forename: Pedro C
authors.initials: PC
authors.lastname: Avila
authors.forename: Esteban González
authors.initials: EG
authors.lastname: Burchard
mesh_terms: D058927:5-Lipoxygenase-Activating Proteins; D000293:Adolescent; D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000208:ethnology / Q000235:genetics; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002352:Carrier Proteins / Q000235:genetics*; D002648:Child; D003430:Cross-Sectional Studies; D004347:Drug Interactions; D004851:Epoxide Hydrolases / Q000235:genetics*; D005260:Female; D006630:Hispanic or Latino / Q000235:genetics*; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D017058:Mexican Americans; D020641:Polymorphism, Single Nucleotide; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D001993:Bronchodilator Agents; D002352:Carrier Proteins; D020024:Leukotriene Antagonists; D008565:Membrane Proteins; D004851:Epoxide Hydrolases; D000420:Albuterol; C043134:leukotriene A4 hydrolase
references.citation: J Immunol. 2009 Jan 15;182(2):1119-28
references.pmid: 19124755
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1329-38
references.pmid: 18559547
references.citation: Ann Allergy Asthma Immunol. 2009 Jun;102(6):510-7
references.pmid: 19558011
references.citation: Pharmacogenet Genomics. 2009 Jul;19(7):489-96
references.pmid: 19503017
references.citation: Lancet. 2007 Dec 22;370(9605):2118-25
references.pmid: 18156033
references.citation: Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):504-9
references.pmid: 10673193
references.citation: Curr Opin Pulm Med. 2009 Jan;15(1):57-62
references.pmid: 19077707
references.citation: Am J Hum Genet. 2004 Sep;75(3):353-62
references.pmid: 15272419
references.citation: Am J Respir Crit Care Med. 2008 Oct 1;178(7):688-94
references.pmid: 18617639
references.citation: Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
references.pmid: 7663792
references.citation: Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120
references.pmid: 742764
references.citation: Allergy. 2008 Aug;63(8):1046-53
references.pmid: 18547289
references.citation: N Engl J Med. 2007 Nov 1;357(18):1841-54
references.pmid: 17978293
references.citation: PLoS Med. 2006 Mar;3(3):e44
references.pmid: 16379500
references.citation: Am J Respir Crit Care Med. 2004 Feb 1;169(3):386-92
references.pmid: 14617512
references.citation: Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
references.pmid: 9872837
references.citation: BMJ. 2004 Jul 10;329(7457):87-8
references.pmid: 15138158
references.citation: Am J Respir Crit Care Med. 2005 Mar 15;171(6):563-70
references.pmid: 15557128
references.citation: Clin Exp Allergy. 2010 Apr;40(4):582-9
references.pmid: 20067482